Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Research Collaboration

Every research collaboration filing by a US-listed company that our alert engine sent, newest first.

8:02 AM ET 8-K
Research Collaboration Oncolytics Biotech Inc ONCY

Oncolytics Biotech Research Collaboration with Coherus Oncology, Inc.

Oncolytics Biotech entered into a clinical supply agreement with Coherus Oncology to evaluate pelareorep in combination with LOQTORZI (toripalimab-tpzi) for the treatment of squamous cell anal carcinoma (SCAC). The clinical study, expected to begin in Q1 2027, will target second-line patients who have progressed on standard-of-care treatments.

Counterparty
Coherus Oncology, Inc.
7:00 AM ET 8-K
Research Collaboration Eton Pharmaceuticals, Inc. ETON

Eton Pharmaceuticals Research Collaboration with Baylor College of Medicine

Eton Pharmaceuticals has entered into a license and development agreement with Baylor College of Medicine to evaluate mecasermin (ET-900) for the treatment of infantile and epileptic spasms. The partnership includes an investigator-sponsored Phase 2 clinical study with patient dosing targeted for Q1 2027, following the submission of an Investigational New Drug application to the FDA.

Counterparty
Baylor College of Medicine

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.